Inappropriate Utilization of Antibiotics in COPD Exacerbations

Yelda Varol1, Zuhal Karakurt2, Ali Kadri Çırak1

  • 1Department of Pulmonology, University of Health Sciences, Dr. Suat Seren Chest Diseases and Surgery Training and Research Hospital, İzmir, Turkey.

Turkish Thoracic Journal
|December 22, 2020
PubMed
Abstract

Insights

Antibiotic prescribing for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is often appropriate, but 36% of prescriptions were not indicated. Patient factors like age or smoking history did not predict inappropriate antibiotic use in AECOPD.

Area of Science:

  • Pulmonary Medicine
  • Infectious Disease
  • Pharmacology

Background:

  • Antibiotics are recommended for severe acute exacerbations of chronic obstructive pulmonary disease (AECOPD) or severe underlying COPD.
  • Most exacerbations are mild to moderate, necessitating careful antibiotic prescription.

Purpose of the Study:

  • To investigate patient factors associated with inappropriate antibiotic prescribing for AECOPD.
  • To evaluate adherence to Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines in AECOPD antibiotic prescriptions.

Main Methods:

  • An observational, cross-sectional study of AECOPD patients prescribed antibiotics in an outpatient setting.
  • Prescriptions were assessed for appropriateness based on GOLD COPD report criteria.
  • Patient data included demographics, spirometry (FEV1%, FVC%), and smoking history.

Main Results:

  • Of 138 patients, 36% received inappropriate antibiotic prescriptions for AECOPD.
  • No significant differences in age, FEV1, FVC, or smoking pack-years were found between appropriate and inappropriate groups.
  • Lower FVC% was statistically associated with appropriate antibiotic prescription (p=0.049).

Conclusions:

  • While most physicians follow GOLD criteria for AECOPD antibiotic prescribing, some self-direct prescriptions.
  • Further research using physician questionnaires is needed to understand reasons for non-adherence in mild AECOPD cases.
  • Optimizing antibiotic use in AECOPD requires understanding physician prescribing behaviors.

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
552
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
831
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.9K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.9K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Antibiotic Selection00:57

Antibiotic Selection

Overview
57.9K